Previous Close | 84.32 |
Open | 84.61 |
Bid | 0.00 x 900 |
Ask | 0.00 x 3000 |
Day's Range | 84.61 - 85.63 |
52 Week Range | 44.98 - 91.39 |
Volume | |
Avg. Volume | 444,837 |
Market Cap | 4.363B |
Beta (5Y Monthly) | 0.35 |
PE Ratio (TTM) | 40.27 |
EPS (TTM) | 2.12 |
Earnings Date | Feb 06, 2023 - Feb 10, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 86.57 |
Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Haemonetics (HAE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Haemonetics (HAE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.